1. Song SH, Chen TL, Deng LP, Zhang YX, Mo PZ, Gao SC, et al. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China. Infect Dis Poverty. 2020;9:82.

https://doi.org/10.1186/s40249-020-00707-1

PMid:32616030 PMCid:PMC7330531

2. Hemmer CJ, Geerdes-Fenge HF, Reisinger EC. COVID-19: Epidemiologische und klinische Fakten [COVID-19: epidemiology and clinical facts]. Radiologe. 2020;60:893-8.

https://doi.org/10.1007/s00117-020-00741-y

PMid:32865603 PMCid:PMC7456747

3. Chen KY, Li T, Gong FH, Zhang JS, Li XK. Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month. Front Psychiatry. 2020;11:668.

https://doi.org/10.3389/fpsyt.2020.00668

PMid:32733299 PMCid:PMC7360857

4. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288:192-206.

https://doi.org/10.1111/joim.13091

PMid:32348588 PMCid:PMC7267177

5. Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254-66.

https://doi.org/10.1016/j.cca.2020.05.044

PMid:32474009 PMCid:PMC7256510

6. Zhang CZ, Cheng XQ, Li JY, Zhang P, Yi P, Xu X, et al. Saliva in the diagnosis of diseases. Int J Oral Sci. 2016;8:133-7.

https://doi.org/10.1038/ijos.2016.38

PMid:27585820 PMCid:PMC5113094

7. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12:8.

https://doi.org/10.1038/s41368-020-0074-x

PMid:32094336 PMCid:PMC7039956

8. Song J, Li Y, Huang X, Chen Z, Li Y, Liu C, et al. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2. J Med Virol. 2020;92:2556-66.

https://doi.org/10.1002/jmv.26045

PMid:32441816 PMCid:PMC7280739

9. Azzi L, Baj A, Alberio T, Lualdi M, Veronesi G, Carcano G, et al. Rapid Salivary Test suitable for a mass screening program to detect SARS-CoV-2: A diagnostic accuracy study. J Infect. 2020;81:e75-8.

https://doi.org/10.1016/j.jinf.2020.06.042

PMid:32579988 PMCid:PMC7306212

10. Azzi L, Carcano G, Gianfagna F, Grossi P, Gasperina DD, Genoni A, et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect. 2020;81:e45-50.

https://doi.org/10.1016/j.jinf.2020.04.005

PMid:32298676 PMCid:PMC7194805

11. Azzi L, Carcano G, Dalla Gasperina D, Sessa F, Maurino V, Baj A. Two cases of COVID-19 with positive salivary and negative pharyngeal or respiratory swabs at hospital discharge: A rising concern. Oral Dis. 2020:10.1111/odi.13368.

https://doi.org/10.1111/odi.13368

PMid:32333518 PMCid:PMC7267504

12. Chau NVV, Thanh Lam V, Thanh Dung N, Yen LM, Minh NNQ, Hung LM, et al. The natural history and transmission potential of asymptomatic SARS-CoV-2 infection. Clin Infect Dis. 2020;71:2679-87.

https://doi.org/10.1093/cid/ciaa711

PMid:32497212 PMCid:PMC7314145

13. Faustini SE, Jossi SE, Perez-Toledo M, Shields A, Allen JD, Watanabe Y, et al. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv. 2020:2020.06.16.20133025.

https://doi.org/10.1101/2020.06.16.20133025

PMid:32588002

14. Fukumoto T, Iwasaki S, Fujisawa S, Hayasaka K, Sato K, Oguri S, et al. Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification. Int J Infect Dis. 2020;98:16-7.

https://doi.org/10.1016/j.ijid.2020.06.074

PMid:32599282 PMCid:PMC7318955

15. Guest JL, Sullivan PS, Valentine-Graves M, Valencia R, Adam E, Luisi N, et al. Suitability and Sufficiency of Telehealth Clinician-Observed, Participant-Collected Samples for SARS-CoV-2 Testing: The iCollect Cohort Pilot Study. JMIR Public Health Surveill. 2020;6:e19731.

https://doi.org/10.2196/19731

PMid:32479412 PMCid:PMC7318863

16. Iwasaki S, Fujisawa S, Nakakubo S, Kamada K, Yamashita Y, Fukumoto T, et al. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva. J Infect. 202 ;81:e145-7.

https://doi.org/10.1016/j.jinf.2020.05.071

PMid:32504740 PMCid:PMC7270800

17. Jamal AJ, Mozafarihashjin M, Coomes E, Powis J, Li AX, Paterson A, et al. Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020:ciaa848.

https://doi.org/10.1101/2020.05.01.20081026

PMid:32584972

18. Lalli MA, Langmade SJ, Chen X, Fronick CC, Sawyer CS, Burcea LC, et al. Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP. medRxiv. 2020;hvaa267.

https://doi.org/10.1101/2020.05.07.20093542

PMid:33098427

19. McCormick-Baw C, Morgan K, Gaffney D, Cazares Y, Jaworski K, Byrd A, et al. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2. J Clin Microbiol. 2020;58:e01109-20.

https://doi.org/10.1128/JCM.01109-20

PMid:32414838 PMCid:PMC7383538

20. Nagura-Ikeda M, Imai K, Tabata S, Miyoshi K, Murahara N, Mizuno T, et al. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020;58:e01438-20.

https://doi.org/10.1128/JCM.01438-20

PMid:32636214 PMCid:PMC7448663

21. Pasomsub E, Watcharananan SP, Boonyawat K, Janchompoo P, Wongtabtim G, Suksuwan W, et al. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin Microbiol Infect. 2020:S1198-743X(20)30278-0.

https://doi.org/10.1016/j.cmi.2020.05.001

PMid:32422408 PMCid:PMC7227531

22. Randad PR, Pisanic N, Kruczynski K, Manabe YC, Thomas D, Pekosz A, et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. medRxiv. 2020:2020.05.24.20112300.

https://doi.org/10.1101/2020.05.24.20112300

PMid:33067270

23. Sullivan PS, Sailey C, Guest JL, Guarner J, Kelley C, Siegler AJ, et al. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples. JMIR Public Health Surveill. 2020;6:e19054.

https://doi.org/10.2196/19054

PMid:32310815 PMCid:PMC7184968

24. Tajima Y, Suda Y, Yano K. A case report of SARS-CoV-2 confirmed in saliva specimens up to 37 days after onset: Proposal of saliva specimens for COVID-19 diagnosis and virus monitoring. J Infect Chemother. 2020;26:1086-9.

https://doi.org/10.1016/j.jiac.2020.06.011

PMid:32571647 PMCid:PMC7293472

25. To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, et al. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis. 2020;71:841-3.

https://doi.org/10.1093/cid/ciaa149

PMid:32047895 PMCid:PMC7108139

26. Valentine-Graves M, Hall E, Guest J, Adam E, Valencia R, Hardee I, et al. At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens. PLoS One. 2020;15:e0236775.

https://doi.org/10.1371/journal.pone.0236775

PMid:32756585 PMCid:PMC7406082

27. Wei S, Kohl E, Djandji A, Morgan S, Whittier S, Mansukhani M, et al. Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2. medRxiv. 2020:2020.06.13.20129841.

https://doi.org/10.1101/2020.06.13.20129841

PMid:32587984

28. Williams E, Bond K, Zhang B, Putland M, Williamson DA. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2. J Clin Microbiol. 2020;58:e00776-20.

https://doi.org/10.1128/JCM.00776-20

PMid:32317257 PMCid:PMC7383524

29. Schafer CA, Schafer JJ, Yakob M, Lima P, Camargo P, Wong DT. Saliva diagnostics: utilizing oral fluids to determine health status. Monogr Oral Sci. 2014;24:88-98.

https://doi.org/10.1159/000358791

PMid:24862597 

30. Vinayachandran D, Balasubramanian S. Salivary diagnostics in COVID-19: Future research implications. J Dent Sci. 2020;15:364-6.

https://doi.org/10.1016/j.jds.2020.04.006

PMid:32328218 PMCid:PMC7177105

31. Pineda-Martínez S, Hernández-Islas JL, Escobedo-Torres MP, Paredes-Alonzo IE, López-Candiani C, Correa D, et al. Immunoglobulin Concentrations in Plasma and Saliva During the Neonatal Period. Pediatr Neonatol. 2016;57:213-8.

https://doi.org/10.1016/j.pedneo.2015.06.005

PMid:26651610 

32. Heaney JLJ, Phillips AC, Carroll D, Drayson MT. The utility of saliva for the assessment of anti-pneumococcal antibodies: investigation of saliva as a marker of antibody status in serum. Biomarkers. 2018;23:115-22.

https://doi.org/10.1080/1354750X.2016.1265009

PMid:27885841 

33. Sabino-Silva R, Jardim ACG, Siqueira WL. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin Oral Investig. 2020;24:1619-21.

https://doi.org/10.1007/s00784-020-03248-x

PMid:32078048 PMCid:PMC7088419

34. Soares CD, Mosqueda-Taylor A, de Carvalho MGF, de Almeida OP. Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein. Br J Dermatol. 2020;10.1111/bjd.19569.

https://doi.org/10.1111/bjd.19569

PMid:33140407 

35. Martín Carreras-Presas C, Amaro Sánchez J, López-Sánchez AF, Jané-Salas E, Somacarrera Pérez ML. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis. 2020;10.1111/odi.13382.

https://doi.org/10.1111/odi.13382

PMid:32369674 PMCid:PMC7267423

36. Soares CD, Carvalho RA, Carvalho KA, Carvalho MG, Almeida OP. Letter to Editor: Oral lesions in a patient with Covid-19. Med Oral Patol Oral Cir Bucal. 2020;25:e563-4.

https://doi.org/10.4317/medoral.24044

PMid:32520921 PMCid:PMC7338069